Oncology Clinical Development Lead (Physician)

SystImmune; Princeton (NJ); On-site; USD 200,000 - 300,000; Full time

Benefits offered by this job

Premium benefits

401(k) match

Paid time off

Holidays

Job summary

SystImmune in Redmond, WA and Princeton, NJ is seeking a Clinical Development Physician to serve as medical director/monitor for oncology trials. You will oversee clinical development activities, ensure protocol compliance, and interact with sites, CROs, and the company to maintain safety and data integrity.

Reporting to the Executive Director, Clinical Development, you will lead medical monitoring, contribute to protocol development, and participate in regulatory discussions.

Qualifications

• MD or equivalent with clinical training; oncology/hematology preferred
• Fellowship in medical oncology/hematology; 1–3+ years in clinical development
• Experience in medical monitoring, protocol development, and data review
• Ability to multi-task and work independently under tight deadlines
• Strong communication with internal and external stakeholders

Responsibilities

• Lead clinical study leadership and design efforts
• Provide medical monitoring and safety oversight across trials
• Coordinate with CROs and sites to ensure protocol adherence
• Prepare clinical documentation and data summaries for partners
• Support regulatory interactions and scientific communications

Skills

Medical monitoring

Clinical protocol development

Clinical data review

Execution mindset

Communication

Education

MD or equivalent with clinical training

Job description

SystImmune in Redmond, WA and Princeton, NJ is seeking a Clinical Development Physician to serve as medical director/monitor for oncology trials. You will oversee clinical development activities, ensure protocol compliance, and interact with sites, CROs, and the company to maintain safety and data integrity.

Reporting to the Executive Director, Clinical Development, you will lead medical monitoring, contribute to protocol development, and participate in regulatory discussions.